# Effects of Exenatide on Postprandial Hyperlipidemia and Inflammation

> **NCT00974272** · PHASE4 · COMPLETED · sponsor: **Carl T. Hayden VA Medical Center** · enrollment: 39 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus
- Impaired Glucose Tolerance

## Interventions

- **DRUG:** Exenatide
- **OTHER:** Normal Saline

## Key facts

- **NCT ID:** NCT00974272
- **Lead sponsor:** Carl T. Hayden VA Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2009-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00974272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00974272, "Effects of Exenatide on Postprandial Hyperlipidemia and Inflammation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00974272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*